Return to search

Microbia Raises $50 Million

Microbia Inc., a Cambridge, Mass.-based antibacterial drug company focused on gastrointestinal disorders, has raised $50 million in Series F funding. Ridgeback Capital led the deal, and was joined by Morgan Stanley and return backers like Fidelity Biosciences, Polaris Venture Partners and Venrock Associates. The company has raised over $200 million in total VC funding since its 1998 inception. www.microbia.com